“…2 Ephedrine has 4 times the adrenergic receptor activity of pseudoephedrine 1,11 and has been associated with sudden death, myocardial infarction, and stroke. 13,14 On December 30, 2003, the FDA published a consumer alert to immediately stop the purchase and use of dietary supplements containing ephedra, 4 and a final rule published by the FDA banned the sale of these products, effective April 12, 2004. 5 Despite the fact that pseudoephedrine is the D-isomer of ephedrine and therefore shares the same mechanism of action, 1,11 the FDA ban did not apply to products containing pseudoephedrine.…”